Martina Hildegard Wiedau
HS Clinical Professor, Neurology, University of California Los Angeles
mwiedau@mednet.ucla.edu
(310) 794-1195
UCLA Neuro
BOX 957334, Neuroscience Research Building 1, Room 475E
Los Angeles, CA 90095
UNITED STATES
Publications
- Hatch J, Barkhaus P, Barnes B, Beauchamp M, Benatar M, Bertorini T, Bowser R, Bromberg M, Brown A, Mascias Cadavid J, Carter GT, Cole N, Crayle J, Dimachkie M, Ennist D, Feldman E, Fullam T, Heiman-Patterson T, Jhooty S, Levine T, Li X, Lund I, Mallon E, Maragakis N, McDermott C, Pattee G, Pierce K, Ratner D, Staats K, Wicks P, Wiedau M, Bedlack R. ALSUntangled #70: caffeine.. Amyotrophic lateral sclerosis & frontotemporal degeneration, 2023.
- Venugopal S, Ghulam-Jhelani Z, Ahn IS, Yang X, Wiedau M, Simmons D, Chandler SH. Early deficits in GABA inhibition parallels an increase in L-type Ca2+ currents in the jaw motor neurons of SOD1G93A mouse model for ALS.. Neurobiology of disease, 2023.
- Ati S, Chhetri D, Wiedau M, Soltanzadeh P, Bordelon Y, Chin RK, Savjani RR. Using Intensity Modulated Radiation Therapy for the Treatment of Sialorrhea in Amyotrophic Lateral Sclerosis.. Advances in radiation oncology, 2022.
- Malik R, Wiedau M. Therapeutic Approaches Targeting Protein Aggregation in Amyotrophic Lateral Sclerosis.. Frontiers in molecular neuroscience, 2020.
- Malik R, Meng H, Wongkongkathep P, Corrales CI, Sepanj N, Atlasi RS, Klärner FG, Schrader T, Spencer MJ, Loo JA, Wiedau M, Bitan G. The molecular tweezer CLR01 inhibits aberrant superoxide dismutase 1 (SOD1) self-assembly in vitro and in the G93A-SOD1 mouse model of ALS.. The Journal of biological chemistry, 2019.
- Wiedau-Pazos M, Wong E, Solomon E, Alarcon M, Geschwind DH. Wnt-pathway activation during the early stage of neurodegeneration in FTDP-17 mice.. Neurobiology of aging, 2007.